These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Author: Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Journal: Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069.
    Abstract:
    Moclobemide was compared with clomipramine for safety and efficacy in 2 groups of 15 patients each with endogenous depression. The drugs were given under double-blind conditions in increasing doses; 1 patient in the moclobemide group dropped out because of lack of efficacy. Mean final improvement on the Hamilton Rating Scale for Depression was 51% in the moclobemide group and 54% in the clomipramine group. Efficacy and tolerance were rated good or very good by 47% (moclobemide) and 53% (clomipramine) (NS). The results indicate that moclobemide is as effective as clomipramine in treating endogenous depression.
    [Abstract] [Full Text] [Related] [New Search]